GSK loses Advair (fluticasone/salmeterol) case in Netherland


GSK loses Advair (fluticasone/salmeterol) case in Netherland.

…GSK said in a statement a court in The Hague had ruled in favour of joint claimants, Novartis units Sandoz BV and Hexal AG, in deciding that the Dutch part of the European patent for Advair, as well as the supplementary protection certificate (SPC), was not valid…

– GSK says considering appeal to a higher court

– Ruling in favour of Novartis units Sandoz, Hexal

Detailed post could be found at Kluwer Patent Blog

English translated version of Advair duch court decision (The SPC blog)

Patent: EP0416951 (Expires with SPC Sep 06, 2013)

Orginal link (1) (2)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s